BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 226 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2021. The put-call ratio across all filers is 1.62 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $8,667,000 | +14.6% | 73,100 | +33.2% | 0.01% | +25.0% |
| Q4 2021 | $7,562,000 | -30.3% | 54,874 | -29.8% | 0.00% | -33.3% |
| Q3 2021 | $10,851,000 | +141.9% | 78,116 | +69.1% | 0.01% | +100.0% |
| Q2 2021 | $4,485,000 | +264.0% | 46,203 | +156.2% | 0.00% | +200.0% |
| Q1 2021 | $1,232,000 | -51.4% | 18,032 | -39.1% | 0.00% | -50.0% |
| Q4 2020 | $2,536,000 | +46.4% | 29,591 | +11.1% | 0.00% | +100.0% |
| Q3 2020 | $1,732,000 | -18.9% | 26,643 | -8.8% | 0.00% | -50.0% |
| Q2 2020 | $2,135,000 | +320.3% | 29,205 | +95.8% | 0.00% | – |
| Q1 2020 | $508,000 | -36.3% | 14,918 | +1.9% | 0.00% | -100.0% |
| Q4 2019 | $797,000 | +139.3% | 14,634 | +83.5% | 0.00% | – |
| Q3 2019 | $333,000 | -71.2% | 7,977 | -69.8% | 0.00% | -100.0% |
| Q2 2019 | $1,155,000 | -3.5% | 26,379 | +13.4% | 0.00% | 0.0% |
| Q1 2019 | $1,197,000 | +79.7% | 23,263 | +30.6% | 0.00% | 0.0% |
| Q3 2017 | $666,000 | – | 17,817 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |